XBiotech (XBIT) Cash from Operations (2014 - 2025)
XBiotech (XBIT) posted quarterly Cash from Operations of 22952000.0 for Q4 2025, down 250.95% year-over-year from 15205235.01 in Q4 2024, and down 438.91% quarter-over-quarter from 4259000.0 in Q3 2025.
XBiotech (XBIT) Cash from Operations (2014 - 2025) Analysis & Trends
XBiotech's Cash from Operations history runs 12 years deep, the most recent figure standing at 22952000.0 for Q4 2025.
- In Q4 2025, Cash from Operations fell 250.95% year-over-year to 22952000.0; the TTM figure through Dec 2025 stood at 39920000.0 (down 28.93% YoY), while the FY2025 annual figure was 39920000.0, down 28.93% from the prior year.
- Cash from Operations for Q4 2025 stood at 22952000.0, down from 4259000.0 in the prior quarter.
- The five-year high for Cash from Operations was 72797000.0 in Q2 2021, with the low at 22952000.0 in Q4 2025.
- The 5-year median for Cash from Operations is 4965500.0 (2022), against an average of 1749350.0.
- The sharpest annual moves came in 2021 and 2022: Cash from Operations jumped 729.3% in 2021, then tumbled 383.2% in 2022.
- XBiotech's Cash from Operations stood at 1759000.0 in 2021, then sank by 79.87% to 3164000.0 in 2022, then declined by 8.5% to 3433000.0 in 2023, then tumbled by 90.5% to 6540000.0 in 2024, then plunged by 250.95% to 22952000.0 in 2025.
- Business Quant data shows XBIT's Cash from Operations at 22952000.0 in Q4 2025, 4259000.0 in Q3 2025, and 5989000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 1.13 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 813.00 Mn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -526.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 462.82 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 326.72 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -88.83 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 728.46 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 360.27 Mn |
| 10 | XBiotech | 68.90 Mn | 68.90 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -22.95 Mn |
| Dec 31, 2025 | -22.95 Mn |
| Sep 30, 2025 | -4.26 Mn |
| Sep 30, 2025 | -4.26 Mn |
| Jun 30, 2025 | -5.99 Mn |
| Jun 30, 2025 | -5.99 Mn |
| Mar 31, 2025 | -6.72 Mn |
| Mar 31, 2025 | -6.72 Mn |
| Dec 31, 2024 | -6.54 Mn |
| Dec 31, 2024 | -6.54 Mn |
| Sep 30, 2024 | -5.85 Mn |
| Sep 30, 2024 | -5.85 Mn |
| Jun 30, 2024 | -11.38 Mn |
| Jun 30, 2024 | -11.38 Mn |
| Mar 31, 2024 | -7.20 Mn |
| Mar 31, 2024 | -7.20 Mn |
| Dec 31, 2023 | -3.43 Mn |
| Dec 31, 2023 | -3.43 Mn |
| Sep 30, 2023 | -1.49 Mn |
| Sep 30, 2023 | -1.49 Mn |